We report the results of a randomized, double-blind, placebo-controlled, 16-week study to evaluate the efficacy and safety of ropinirole, 0.75 to 15.0 mg/day, as an adjunct to levodopa. A total of 243 patients were randomly assigned into placebo or ropinirole groups. The mean (standard deviation) dose of ropinirole at endpoint was 7.12 (2.88) mg/day. The primary endpoint-the mean reduction in the Unified Parkinson's Disease Rating Scale (UPDRS) total motor score-was significantly greater for the ropinirole group than the placebo group (-9.5 vs. -4.5, P = 0.00001). The mean reduction in the UPDRS total activities of daily living (ADL) score was also significantly greater for ropinirole than for placebo (-2.7 vs. -1.0, P = 0.0002). The percentage of patients showing at least a 20% reduction in the percentage of time spent "off" was significantly greater for the ropinirole group than for the placebo group (58.7% vs. 38.6%, P = 0.030). A total of 84.3 and 65.6% of the patients experienced adverse events while receiving ropinirole or placebo, respectively. The results showed that ropinirole was more effective than placebo in improving motor function and ADL when used as an adjunct to levodopa in patients with advanced Parkinson's disease.
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Publishing Authors By Initials
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: Movement disorders : official journal of the Movem
VOLUME: 22
Page Numbers: 1860-5
Journal Abbreviation: Mov. Disord.
ISSN: 0885-3185
DAY: 15
MONTH: Oct
YEAR: 2007
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 8610688
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
AFFILIATION: Department of Neurology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan. y-Mizuno@med.juntendo.ac.jp
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Mov Disord
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study Related Publications